Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion type Assertion NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_head.
- NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion description "[In the present study, we performed adoptive immunotherapy (AIT) with tumor-associated lymphocytes (TAL) in patients with gastric (n = 11) and colon (n = 3) cancer with stage IV and investigated whether the alteration of signal transducing molecules was observed with AIT, compared to an untreated control group (n = 13).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_provenance.
- NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion evidence source_evidence_literature NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_provenance.
- NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion SIO_000772 9766562 NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_provenance.
- NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion wasDerivedFrom befree-20140225 NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_provenance.
- NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_assertion wasGeneratedBy ECO_0000203 NP775228.RAkDgDL_owXSbp0ayMnIs9Ri8F8MDe5PBUCH6AaAt_Syc130_provenance.